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ABSTRACT:  A formal total synthesis of manzacidin B is described.  b,b-Disubstituted g-hydroxy-b-aminoalcohol, the key structure 
of manzacidin B, is stereoselectively constructed via sequential Henry reactions.  By taking advantage of noncovalent interactions, 
such as intramolecular hydrogen bonding and chelation, we could diastereodivergently control the stereoselectivity of the Henry 
reaction.   
INTRODUCTION 
Bromopyrrole alkaloids,1 a large family of marine natural 
products, are known to be a rich source of biologically active 
molecules, such as sceptrin,2 dispacamide B3 and spongiacidin 
B.4  Manzacidins A–C, a rare class of these alkaloids, are 
isolated from Okinawan sponge Hymeniacidon sp. by 
Kobayashi and colleagues in 1991 (Figure 1).5  The structural 
features of manzacidins A–C are a bromopyrrole carboxylic 
acid and a highly substituted tetrahydropyrimidine core.  
Because of their unique structure and pharmacological profile 
as in a class of bromopyrrole alkaloids, manzacidins are 
attractive target molecules for organic synthesis.6  Therefore, a 
number of synthesis, targeting manzacidins A and C,7 have been 
developed based on variety of methodologies constructing b,b-
disubstituted b-aminoalcohol8 moiety composed of the 
nitrogen-containing tetrasubstituted carbon.   
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Recently, we also have achieved stereoselctive synthesis of 
manzacidins A and C based on Henry reaction of chiral 
nitroalkane 1.9,10  In this study, we have found that in the key 
Henry reaction, the use of different protecting groups 
diastereodivergently produces both isomers of tertiary 
nitroalkanes 2a and 2b, which could be converted to 
manzacidins A and C respectively (Scheme 1).   
In contrast to manzacidins A and C, only two groups have 
reported the stereoselective synthesis of manzacidin B,11 which 
has an additional hydroxy group at C5 position as a part of three 
contiguous stereogenic center and a characteristic b,b-
disubstituted g-hydroxy-b-aminoalcohol structure.  Considering 
this b-aminoalcohol motif as a Henry retron, we envisioned that 
this natural product could also be synthesized via Henry 
reaction as in our synthesis of manzacidin A and C.9  Herein, 
we report a formal total synthesis of manzacidin B based on the 
substrate-controlled diastereoselective Henry reaction.   
 
RESULTS AND DISCUSSION 
Scheme 2 shows our plan for the synthesis of manzacidin B.  
We set Mohapatra’s synthetic intermediate 311c as the target 
compound, since 3 can be readily converted to manzacidin B.  
Compound 3 is retrosynthetically converted to tertiary b,b’-
dihydroxynitroalkane (4S,5R,6R)-4 via oxidative lactonization 
and reduction of the nitro group.  Consideration of the Henry 
disconnection allowed us to devise two pathways to construct 
(4S,5R,6R)-4.  In route A, (4S,5R,6R)-4 would be synthesized 
by the coupling of 1-hydroxy-2-nitropropane and chiral 
aldehyde (4S)-5, constructing both C-5 and C-6 stereogenic 
center in a single Henry reaction.  Alternatively, in route B, 
(4S,5R,6R)-4 would also be synthesized through sequential 
Henry reactions connecting two aldehydes, formaldehyde and 
chiral aldehyde (4S)-5, with nitroethane.  In this route, the 
stereochemistry of C5 and C6 could be stepwisely controlled.  
Since the route A is more straightforward than the route B, our 
study commenced with an investigation of the Henry reaction 




Scheme 2. Retrosynthesis of manzacidin B 
 
Table 1. Henry Reaction of 7 with (4S)-5a 
 
aThe reaction of the nitroalkane (3 equiv) with (4S)-5a (0.2 
mmol) was conducted in the presence of DBU (90 mol%) in THF 
at –50 °C for 19 h.  bThe reaction of the nitroalkane (10 equiv) with 
(4S)-5a (0.2 mmol) was conducted in the presence of Et3N (30 
mol%) and the thiourea (30 mol%) under the solvent-free 
conditions at 0 °C for 2 h.  cIsolated yield.  dThe dr was evaluated 
by 1H NMR analysis.   
 
Table 1 shows our study on the Henry reaction of TBS-
protected 1-hydroxy-2-nitropropane with (4S)-5a.12  When the 
reaction of the nitroalkane (3 equiv) with (4S)-5a was 
conducted in the presence of DBU (90 mol%),10 a significant 
amount of the nitroalkane was decomposed, and only 22% yield 
of adduct 4a was obtained as a mixture of four diastereomers 
(dr 1.6:1.6:1.2:1).  To suppress the decomposition of the 
nitroalkane, we next examined the reaction under less-basic 
conditions.  As a result, we found that the combination use of 
Et3N and 3,5-bis(trifluoromethyl)phenylthiourea (30 mol% 
each) under solvent-free (10 equiv of the nitroalkane was used) 
conditions successfully improved the yield of 4a (70%).  
However, diastereoselectivity was quite poor (dr 1.7:1.6:1.1:1).   
Based on the results shown in Table 1, we concluded that it 
was difficult to control the diastereoselectivity in the Henry 
reaction of 1-hydroxy-2-nitropropane derivatives with chiral 
aldehyde (4S)-5a.  Thus, we next investigated the sequential 
Henry reactions (route B).  In this synthetic route, intermediate 
(4S,5R)-6, a b-hydroxynitroalkane, would also be unstable 
under strong basic conditions.  Therefore, mild basic conditions 
were employed for the first Henry reaction of nitroethane with 
(4S)-5 (Table 2).  When the reaction of nitroethane (5 equiv) 
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the corresponding adduct 6a was successfully obtained in 83% 
yield (entry 1).  However, undesired (4S,5S)-6a was generated 
as a major isomer (5R/5S = 1:5.0).  In sharp contrast, when O-
TBS-protected (4S)-5b was used as the substrate, desired 
(4S,5R)-6b was obtained preferentially (78% yield, 5R/5S = 
2.0:1, entry 2).  The use of O-Tr-protected (4S)-5c as the 
substrate also gave (4S,5R)-6c as a major product (64% yield, 
5R/5S = 2.0:1, entry 3).  To improve the diastereoselectivity, we 
investigated several bases, and found that when the reaction of 
(4S)-5c was conducted in the presence of nBu4NF (30 mol%),14 
diastereoselectivity was increased to 5R/5S = 6.5:1 (89% yield, 
entry 4).  Further investigation revealed that the use of nBu4PBr 
(10 mol%) and KF (10 equiv) improved the diastereoselectivity 
(90% yield, 5R/5S = 11:1, entry 5).   
Although the stereoselectivity at C5 was high in the first 
Henry reaction, adduct 6c was obtained as a ca. 1:1 
diastereomeric mixture at C6.  However, we did not make 
efforts to control the C6-stereochemistry at this stage, since it 
would be lost at the second Henry reaction.  C6-diastereomers 
of 6c (named as 6ca and 6cb) were separable on silica gel 
column chromatography, and 6ca and 6cb were isolated in 
respective yields of 44 and 46%.15   
 
Table 2. Investigation of the 1st Henry Reactiona 
 
entry 5 catalyst yield (%)b 5R/5Sc 
1d 5a KF 6a, 83 1:5.0 
2 5b Et3N 6b, 78 2.0:1 
3 5c Et3N 6c, 64 2.0:1 
4 5c nBu4NF 6c, 89 6.5:1 
   5e,f 5c nBu4PBr, KF 6c, 90 11:1 
aThe reaction of (4S)-5 (0.2 mmol) was conducted in the 
presence of a catalyst (30 mol%) in EtNO2 at 0 °C for 1.5–24 h.  
bIsolated yield.  cEvaluated by 1H NMR analysis.  dThe reaction was 
conducted with EtNO2 (5 equiv) in the presence of KF (20 mol%) 
in i-PrOH–benzene (10:1).  eThe reaction was conducted in the 
presence of nBu4PBr (10 mol%) and KF (10 equiv).  fThe reaction 
was conducted on 1.0 mmol scale. 
 
Here we propose mechanisms for the first Henry reaction 
with (4S)-5 (Scheme 3).  The stereoselectivity of the reaction 
with (4S)-5a could be explained by the polar Felkin–Anh 
model16 as shown in the upper scheme.  The nitronate would 
approach the Re face of (4S)-5a to give (4S,5S)-6a 
preferentially.  On the other hand, in the transition-state 
assembly for the reaction of (4S)-5c, the formyl group might 
interact with the NH group via intramolecular hydrogen 
bonding (bottom Scheme).17  The trityloxymethyl group would 
shield the front side of the formyl group, and the nitronate was 
considered to approach the Si face of the formyl group (from 
the back side) to give the desired (4S,5R)-6c as a major product.  
The reason why the use of tetrabutylammonium and 
phosphonium salts improved the diastereoselectivity was 
considered to be the fact that these aprotic and sterically 
hindered countercations did not disrupt the formation of the 
intramolecular hydrogen bonding.   
 
 
Scheme 3. Proposed transition-state assemblies 
 
Before the second Henry reaction, C5-hydroxy group of 
(4S,5R)-6c should be protected to avoid the retro-Henry 
reaction.  Therefore, compound (4S,5R)-6c was converted into 
acetonide-protected (4S,5R)-7c (Scheme 4).  To avoid the 
confusion, C6-diastereomers (4S,5R)-6ca and (4S,5R)-6cb, 
were converted into (4S,5R)-7ca and (4S,5R)-7cb separately.  
Removal of trityl group under the acidic conditions, followed 
by acetonide protection of the resultant diols, gave 6-membered 
acetonides (4S,5R)-7ca and (4S,5R)-7cb in respective yields of 
60 and 49%.  In this reaction scheme, 5-membered acetonides 
(4S,5R)-8ca and (4S,5R)-8cb were also generated in respective 
yields of 13 and 5%.   
 
 
Scheme 4. Synthesis of secondary nitroalkane (4S,5R)-7c 
 
With chiral nitroalkane (4S,5R)-7c in hand, we investigated 
the second Henry reaction constructing the nitrogen-containing 
tetrasubstituted carbon (Table 3).  Since acetonide-protected 
(4S,5R)-7c was found to be rather stable under strong basic 
conditions, the reaction of (4S,5R)-7ca with paraformaldehyde 
was conducted in the presence of a variety of strong bases.  
When the reaction was conducted in the presence of DBU (200 


























(4S)-5a:  pg1, pg2 = C(CH3)2
(4S)-5b:  pg1 = H, pg2 = TBS
























































a single diastereomer (entry 1).  In contrast, the use of NaOt-Bu 
(30 mol%) gave desired (4S,5R,6R)-4c as a major isomer (81% 
yield, 6R/6S = 4.0:1) (entry 2).  Based on these results, we 
considered that the presence of a metal cation would result in 
the desired diastereopreference via chelation.  Therefore, to 
improve the diastereoselectivity, we screened several alkaline 
earth metal salts as additives.  As results, although BaCl2 did 
not improve the diastereoselectivity (entry 3), the use of CaCl2 
and MgCl2·6H2O slightly improved the diastereoselectivity 
(entries 4 and 5).  To our delight, we found that when 
MgCl2·6H2O was dried under heat and vacuum conditions 
before use, the diastereoselectivity was further improved to 
6R/6S = 6.0:1 (entry 6).  In sharp contrast, very surprisingly, the 
use of anhydrous MgCl2 significantly decreased both the yield 
and diastereoselectivity (37%, 6R/6S = 1:3.8), and undesired 
(4S,5R,6S)-4c was obtained as a major product (entry 7).  The 
“activated” magnesium salt used in entry 6 could be a partially 
dehydrated MgCl2·nH2O, although we have no structural 
evidence at this point.  Regardless, the results shown in entry 6 
were reproducible and scalable (2 mmol scale, 91% yield, 6R/6S 
= 6.0:1). 
Diastereomeric (4S,5R)-7cb was also converted to desired 
(4S,5R,6R)-4c under the same conditions in 80% yield with a 
5:1 diastereomeric ratio (Scheme 5).   
 
Table 3. Investigation of the 2nd Henry reactiona 
 
entry base metal salt yield 
(%)b 
6R/6Sc 
1d DBU (200 mol%) — 89 1:>20 
2 NaOt-Bu (30 mol%) — 81 4.0:1 
3 NaOt-Bu (60 mol%) BaCl2 91 3.7:1 
4 NaOt-Bu (60 mol%) CaCl2 81 4.3:1 
5e NaOt-Bu (60 mol%) MgCl2·6H2O 83 4.5:1 
6f NaOt-Bu (60 mol%) MgCl2·6H2O 92 6.0:1 
7e NaOt-Bu (60 mol%) MgCl2 37 1:3.8 
aThe reaction of (4S,5R)-7ca (0.2 mmol) with paraformaldehyde 
(3 equiv) was conducted in the presence of a base (30–200 mol%) 
and a metal salt (30 mol%) in THF at 0 °C for 1.5–2 h.  bIsolated 
yield.  cEvaluated by 1H NMR analysis.  dThe reaction was 
conducted in CH2Cl2 at –50 °C for 24 h.  eThe reaction was 
conducted at ambient temperature.  fMgCl2·6H2O was dried by a 
heat-gun under vacuum for five minutes. 
 
 
Scheme 5. Conversion of (4S,5R)-7cb to (4S,5R,6R)-4c 
 
The diastereoselectivity of the second Henry reaction could 
be explained with the following models (Scheme 6).  In the 
DBU-promoted reaction, the nitronate intermediate would have 
a conformation in which the allylic strain is the smallest in 
energy (upper scheme).  The N-Boc group would shield the 
back side of the nitronate moiety.  Thus, formaldehyde was 
considered to approach the front side (Si face) of the nitronate 
moiety, avoiding the steric repulsion of the N-Boc group.  On 
the other hand, in the presence of magnesium salt, magnesium 
cation would interact with the oxygens of the nitronate group 
and acetonide group in the nitronate intermediate (bottom 
scheme).  In this fixed conformation, the N-Boc group would 
shield the upper face of the nitronate moiety.  Formaldehyde 
was thus considered to approach the bottom side (Re face) of 
chelated magnesium nitronate to establish the desired 6R-




Scheme 6. Proposed transition state-assemblies 
 
With compound (4S,5R,6R)-4c, which bears all of the 
stereogenic center that correspond to manzacidin B, in hand, we 
converted (4S,5R,6R)-4c to Mohapatra’s intermediate (3) via 
functional group manipulations (Scheme 7).  Reduction of the 
nitro group of (4S,5R,6R)-4c using Zinc dust18 followed by Boc 











































































dicarbamate 9 in 60% yield (two steps).  The acetonide group 
of 9 was then removed under acidic conditions to give triol 10 
in 76% yield.  In the final step of our synthesis, 10 was 
converted to Mohapatra’s intermediate (3) via oxidative 
lactonization with TEMPO and PhI(OAc)211c in 81% yield.  The 
spectral data of synthetic 3 were identical to the reported data.11c  
Thus, our diastereoselective Henry reaction-based synthetic 
approach allowed us to achieve a stereoselective formal total 




Scheme 7. Formal total synthesis of manzacidin B 
 
CONCLUSION 
In conclusion, we have achieved a formal total synthesis of 
manzacidin B:  the total number of processes from the known 
aldehyde 5c to Mohapatra’s synthetic intermediate 3 has 
included 8 steps and the overall yield has been 11%.  The b,b-
disubstituted g-hydroxy-b-aminoalcohol, the key structure of 
manzacidin B, was diastereoselectively constructed via 
sequential Henry reactions of nitroethane with two aldehydes.  
By taking advantage of noncovalent interactions such as 
intramolecular hydrogen bonding and chelation, we could 
diastereodivergently control the stereoselectivity of the Henry 
reactions.  Therefore, the present method could allow us to 
synthesize not only the natural isomer but C5- and C6-
diastereomers of manzacidin B diastereoselectively.  Since the 
substrate-controlled reaction sequence is practical and 
economical, it should provide us an opportunity for the scalable 
production of manzacidin B. 
 
EXPERIMENTAL SECTION 
General Experimental Information.  All reactions were 
conducted in flame-dried glassware under a nitrogen 
atmosphere with dry solvents, unless noted. All reagent and 
starting material were purchased from commercial sources and 
used as supplied, unless otherwise noted. Anhydrous 
tetrahydrofuran (THF), dichloromethane (CH2Cl2), and 
diethylether (Et2O) were purchased from Kanto Chemical. 
Anhydrous toluene was purchased from FUJIFILM Wako Pure 
Chemical.   
IR spectra were recorded on a SHIMADZU FTIR-8400 
spectrometer.  1H spectra were recorded on a Varian NMR 
System 600 PS600 spectrometer (600 MHz) and a Varian 400-
MR ASW spectrometer (400 MHz) at ambient temperature.  
Data were recorded as follows: chemical shift in ppm from the 
solvent resonance employed as the internal standard (CHCl3 at 
7.26 ppm) on the d scale, multiplicity (s = singlet; d = doublet; 
t = triplet; q = qualtet; quin = quintet; br = broad; m = multiplet), 
coupling constant (Hz), and integration.  13C NMR spectra were 
recorded on a Varian NMR System 600 PS600 spectrometer 
(150 MHz) and a Varian 400-MR ASW spectrometer (100 
MHz) at ambient temperature.  Chemical shifts were recorded 
in ppm from the solvent resonance employed as the internal 
standard (CDCl3 at 77.0 ppm).  Optical rotations were measured 
on a digital polarimeter Horiba SEPA-300 using a 3.5 mm × 0.5 
dm pyrex cell.  TLC analyses were performed on Merck 
precoated TLC plates (silica gel 60 F254 0.25 mm) and the spots 
were visualized by UV-light (254 nm) or phosphomolybdic acid 
stain and anisaldehyde stain. Column chromatography was 
performed on Kanto silica gel 60 N (spherical, neutral).  High 
resolution mass spectral analyses (HRMS) were measured on 
Bruker micrOTOF II [electrospray ionization (ESI)/time-of-
flight] and JEOL JMS-700 MStation [fast atom bombardment 
(FAB)/double-focusing magnetic sector] at Chemical 
Instrument Facility, Okayama University. 
Henry reaction of 7 with (4S)-5a. 
tert-Butyl (4S)-4-(1,3-Dihydroxy-2-methyl-2-nitropropyl)-
2,2-dimethyloxazolidine-3-carboxylate [4a] 
< Et3N and thiourea-catalyzed method > 
To a mixture of (4S)-5a (51.0 mg, 0.222 mmol) and 1-(tert-
butyldimethylsilyloxy)-2-nitropropane (498 mg, 2.22 mmol) 
were added 3,5-bis(trifluoromethyl)phenylthiourea (33.3 mg, 
66.6 µmol) and Et3N (10.0 µL, 66.6 µmol) at 0 °C.  After being 
stirred at the same temperature for 2 h, the reaction was 
quenched by the addition of saturated aqueous solution of 
NH4Cl at 0 °C, and extracted with EtOAc.  The organic layer 
was dried over Mg2SO4, filtered and concentrated in vacuo to 
give the crude product.  The residue was purified by column 
chromatography on silica gel (hexane–EtOAc 5:1) to afford 4a 
(69.7 mg, 0.155 mmol, 70%) as a diastereomeric mixture 
(relative stereochemistry was not determined). 
Diastereomeric ratio of 4a (1.7:1.6:1.1:1) was determined by 
1H NMR analysis comparing the characteristic peaks observed 
at d 0.04 (s, 6H), d 0.05 (s, 6H), d 0.06 (s, 6H) and d 0.07 (s, 
6H). 
4a (mixture of four diastereomers): colorless oil; IR (film) 
3493, 3020, 2931, 2858 1693, 1548, 1392, 1367, 1255, 1215, 
840, 756 cm–1; 1H NMR (400 MHz, CDCl3) d 4.40–3.99 (m, 
33.3H), 3.96–3.82 (m, 12.0H), 1.61–1.54 (m, 18.5H), 1.53–1.44 
(m, 72.2H), 0.86–0.84 (m, 54.9H), 0.073 (s, 6.00H), 0.062 (s, 
6.71H), 0.052 (s, 9.93H), 0.038 (s, 10.3H); HRMS (ESI) m/z 
calcd for C20H40N2NaO7Si [M+Na]+ 471.2502, found 471.2499. 
< DBU-catalyzed method > 
To a solution of (4S)-5a (68.8 mg, 0.300 mmol) and 1-(tert-
butyldimethylsilyloxy)-2-nitropropane (198 mg, 0.900 mmol) 
in THF (3 mL) were added DBU (40.0 µL, 0.270 mmol) at –
50 °C.  After being stirred at the same temperature for 19 h, the 
reaction was quenched by the addition of saturated aqueous 
solution of NH4Cl at –50 °C, and extracted with EtOAc.  The 
organic layer was dried over Mg2SO4, filtered and concentrated 
in vacuo to give the crude product.  The residue was purified by 
column chromatography on silica gel (hexane–EtOAc 5:1) to 
afford 4a (29.1 mg, 64.9 µmol, 22%) as a diastereomeric 
mixture.  Diastereomeric ratio (1.6:1.6:1.2:1) was determined 
by 1H NMR as above. 
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dimethyloxazolidine-3-carboxylate [(4S,5R)-6a] and 
(4R)-tert-Butyl-4-((1S)-hydroxy-2-nitropropyl)-2,2-
dimethyloxazolidine-3-carboxylate [(4S,5S)-6a] 
To a solution of (4S)-5a (45.8 mg, 0.200 mmol) in i-PrOH–
benzene = 10:1 (2.20 mL) were added nitroethane (71.5 µL, 
1.00 mmol) and KF (2.30 mg, 40 µmol) at ambient temperature.  
After being stirred at same temperature for 24 h, the mixture 
was diluted with CH2Cl2 and filtered through a pad of Celite®.  
After concentrated in vacuo, the residue was dissolved in 
CH2Cl2, washed with brine and dried over MgSO4. The residue 
was subjected to column chromatography on silica gel 
(CH2Cl2–EtOAc 10:1) to afford (4S,5R)-6a (8.3 mg, 27.5 µmol, 
14%, 1:1 mixture of diastereomers at C6) and (4S,5S)-6a (42.0 
mg, 0.138 mmol, 69%, 2:1 mixture of diastereomers at C6) 
Diastereomeric ratio of (4S,5R)-6a (1:1) was determined by 
1H NMR analysis comparing the characteristic peaks observed 
at d 4.64 (app quin, 1H) and d 4.49 (br s, 1H).  Diastereomeric 
ratio of (4S,5S)-6a (2:1) was determined by 1H NMR analysis 
comparing the characteristic peaks observed at d 4.58 (dq, 1H, 
major diastereomer) and d 4.54 (app quin, 1H, minor 
diastereomer). In both cases relative stereochemistry of C6 was 
not determined. 
(4S,5R)-6a (1:1 mixture of diastereomers): colorless oil; IR 
(film) 3446, 3024, 2981, 1698, 1652, 1556, 1367 cm–1; 1H NMR 
(600 MHz, CDCl3) d 4.64 (app quin, J = 5.4 Hz, 1H), 4.49 (br 
s, 1H), 4.40 (br s, 1H), 4.21–4.13 (br s, 1H), 4.10–4.00 (m, 1H: 
overlapped with diastereomer 1H), 3.95–3.90 (m, 1H: 
overlapped with diastereomer 1H), 3.89–3.84 (m, 1H), 3.83–
3.76 (br s, 1H), 1.63 (d, J = 6.6 Hz, 3H), 1.61–1.54 (m, 9H), 
1.49 (s, 3H), 1.48 (s, 3H), 1.47 (s, 9H: overlapped with 
diastereomer 9H); 13C{1H} NMR (150 MHz, CDCl3) d 155.2, 
94.5, 84.6, 84.2, 82.2, 81.9, 76.1, 74.9, 65.5, 64.4, 59.4, 58.8, 
28.2, 27.0, 23.9, 15.8, 11.7; HRMS (FAB) m/z calcd for 
C13H25N2O6 [M+H]+ 305.1707, found 305.1732.   
(4S,5S)-6a (major diastereomer : minor diastereomer = 2:1, 
only characteristic peaks of minor diastereomer were 
described): colorless oil; IR (film) 3440, 3021, 2981, 1690, 
1651, 1552, 1367cm–1; 1H NMR (600 MHz, CDCl3) d 4.58 (dq, 
J = 6.6, 2.4 Hz, 1H), 4.54 (app quin, J = 6.0 Hz, 0.5H: minor 
diastereomer), 4.22 (app d, J = 4.8 Hz, 1H), 4.20–4.15 (m, 0.5H: 
minor diastereomer), 4.14 (app d, J = 9.0 Hz, 1H), 4.11–4.05 
(m, 0.5H: minor diastereomer), 4.04–3.90 (m, 2H: overlapped 
with minor diastereomer 0.5H), 3.83 (br s, 0.5H: minor 
diastereomer), 3.68 (br s, 1H), 2.90 (br s, 0.5H: minor 
diastereomer) 1.64 (d, J = 6.6 Hz, 3H: overlapped with minor 
diastereomer 1.5H), 1.59–1.53 (m, 3H, minor diastereomer 
1.5H×2), 1.52–1.44 (m, 12H: overlapped with minor 
diastereomer 4.5H); 13C{1H} NMR (150 MHz, CDCl3) d 153.9, 
94.5 (minor diastereomer), 84.9 (minor diastereomer), 84.3, 
81.5, 73.4, 73.1, 64.8, 63.8 (minor diastereomer), 59.4 (minor 
diastereomer), 58.9, 28.3, 27.4, 26.9 (minor diastereomer), 23.9, 
22.6 (minor diastereomer), 16.7, 12.8 (minor diastereomer); 
HRMS (FAB) m/z calcd for C13H25N2O6 [M+H]+ 305.1707, 
found 305.1737.   
tert-Butyl ((2S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-
hydroxy-4-nitropentan-2-yl)carbamate  [(4S,5R)-6b] and 
tert-Butyl ((2S,3S)-1-((tert-Butyldimethylsilyl)oxy)-3-
hydroxy-4-nitropentan-2-yl)carbamate [(4S,5S)-6b] 
To a solution of (4S)-5b19 (60.5 mg, 0.200 mmol) in EtNO2 
(2.00 mL) was added triethylamine (8.40 µL, 59.8 µmol) at 0 °C.  
After being stirred at same temperature for 1.5 h, the mixture 
was diluted with water, and extracted with EtOAc.  The organic 
layer was washed with brine, dried over MgSO4 and 
concentrated in vacuo to give the crude product.  The residue 
was subjected to column chromatography on silica gel (hexane–
EtOAc 20:1) to afford 6ba (39.4 mg, 0.104 mmol, 52%, mixture 
of diastereomers at C5, 5R/5S =2:1) and 6bb (19.8 mg, 0.0522 
mmol, 26%, mixture of diastereomers at C5, 5R/5S =2:1). 6ba 
and 6bb are stereoisomers at C6, but relative stereochemistry 
was not determined. 
Diastereomeric ratio of 6ba (5R/5S =2:1) was determined by 
1H NMR analysis comparing the characteristic peaks observed 
at d 4.79 (app quin, 1H, 5R isomer) and d 4.61 (app quin, 1H, 
5S isomer).  Diastereomeric ratio of 6bb (5R/5S =2:1) was 
determined by 1H NMR analysis comparing the characteristic 
peaks observed at d 4.67 (qd, 1H, 5S isomer) and d 4.59 (qd, 
1H, 5R isomer). 
 
6ba (5R isomer : 5S isomer = 2:1, only characteristic peaks 
of 5S isomer were described): colorless oil; IR (film) 3440, 
3348, 3020, 2929, 2858, 1698, 1695, 1558, 1456 cm–1; 1H NMR 
(600 MHz, CDCl3) d 5.16 (d, J = 9.6 Hz, 1H), 4.99 (d, J = 8.4 
Hz, 0.5H: 5S isomer), 4.67 (qd, J = 6.6, 3.0 Hz, 0.5H: 5S isomer), 
4.59 (qd, J = 9.6, 6.6 Hz, 1H), 4.34 (app d, J = 9.6 Hz, 1H), 4.24 
(ddd, J = 8.4, 5.4, 3.0 Hz, 0.5H: 5S isomer), 4.04 (dd, J = 10.2, 
2.4 Hz, 0.5H: 5S isomer), 3.86 (app d, J = 4.2 Hz, 2H), 3.74 (dt, 
J = 9.6, 4.2 Hz, 1H), 3.69 (dd, J = 10.2, 3.6 Hz, 0.5H: 5S isomer), 
3.64 (d, J = 2.4 Hz, 1H: 5S isomer, 3.62–3.57 (m, 0.5H: 5S 
isomer), 3.13 (d, J = 5.4 Hz, 0.5H: 5S isomer), 1.66 (d, J = 6.6 
Hz, 1.5H: 5S isomer), 1.55 (d, J = 6.6 Hz, 3H), 1.45 (s, 9H: 
overlapped with 5S isomer 4.5H), 0.89 (s, 9H: overlapped with 
5S isomer 4.5H), 0.09 (s, 6H: overlapped with 5S isomer 3H); 
13C{1H} NMR (150 MHz, CDCl3) d 155.6, 86.0, 84.3 (5S 
isomer), 80.2, 74.8, 72.1 (5S isomer), 65.9, 62.5 (5S isomer), 
51.9 (5S isomer), 50.1, 28.3, 25.83, 25.77, 18.2 (5S isomer), 
18.1, 16.0, 12.8 (5S isomer), –5.59, –5.65 (5S isomer); HRMS 
(FAB) m/z calcd for C13H25N2O6 [M+H]+ 305.1707, found 
305.1732.   
6bb (5R isomer : 5S isomer = 2:1, only characteristic peaks 
of 5S isomer were described): colorless oil; IR (film) 3438, 
3384, 2981, 2858, 1685, 1618, 1560, 1458 cm–1; 1H NMR (600 
MHz, CDCl3) d 5.21 (d, J = 8.4 Hz, 1H), 5.11 (d, J = 8.4 Hz, 
0.5H: 5S isomer), 4.79 (app quin, J = 6.6 Hz, 1H), 4.61 (app 
quin, J = 6.6 Hz, 0.5H: 5S isomer), 4.38 (app d, J = 4.8 Hz, 
0.5H: 5S isomer), 4.06 (br s, 1H), 3.85 (dd, J = 10.2, 4.2 Hz, 
1H), 3.83–3.78 (m, 1H: overlapped with 5S isomer 1H), 3.78–
3.73 (m, 1H), 3.63–3.55 (m, 1H: overlapped with 5S isomer 
0.5H), 1.62 (d, J = 6.6 Hz, 1.5H: 5S isomer), 1.58 (d, J = 6.6 Hz, 
3H), 1.44 (s, 9H: overlapped with 5S isomer 4.5H), 0.90 (s, 9H), 
0.89 (s, 4.5H: 5S isomer), 0.09, (s, 6H), 0.078 (s, 1.5H: 5S 
isomer), 0.075 (s, 1.5H: 5S isomer); 13C{1H} NMR (150 MHz, 
CDCl3) d 155.3, 85.8, 84.1 (5S isomer), 80.1, 74.9, 73.1 (5S 
isomer), 65.3 (5S isomer), 62.8, 52.1, 51.0, 28.3, 25.8, 18.1, 
16.3, 14.9 (5S isomer), –5.59; HRMS (FAB) m/z calcd for 
C13H25N2O6 [M+H]+ 305.1707, found 305.1732.   
tert-Butyl ((2S,3R)-3-Hydroxy-4-nitro-1-(trityloxy)pentan-2-




To a solution of (4S)-5c20 (468 mg, 1.09 mmol) in EtNO2 
(10.0 mL) was added tetrabutylphosphonium bromide (36.9 mg, 
0.109 mmol) and KF (633 mg, 10.9 mmol) at 0 °C.  After being 
stirred at same temperature for 1.5 h, the reaction was quenched 
by the addition of saturated aqueous NH4Cl solution at 0 °C, 
and extracted with CH2Cl2.  The organic layer was dried over 
Na2SO4, filtered and concentrated in vacuo to give the crude 
product. The residue was subjected to column chromatography 
on silica gel (hexane–EtOAc 15:1) to afford 6ca (244 mg, 0.482 
mmol, 44%, 5R/5S >20:1) and 6cb (252 mg, 0.497 mmol, 46%, 
mixture of diastereomers at C5, 5R/5S =5:1). 6ca and 6cb are 
stereoisomers at C6, but relative stereochemistry was not 
determined. 
Diastereomeric ratio of 6cb (5R/5S =5:1) was determined by 
1H NMR analysis comparing the characteristic peaks observed 
at d 5.06 (d, 1H, 5R isomer) and d 4.96 (d, 1H, 5S isomer).  
6ca: Colorless solid; mp 62–64 °C; [a]27D –30.2 (c 0.50, 
CHCl3); IR (film) 3428, 3059, 2978, 2880, 1713, 1549, 1165, 
750 cm–1; 1H NMR (400 MHz, CDCl3) d 7.43–7.37 (m, 6H), 
7.36–7.24 (m, 9H: overlapped with CHCl3), 5.11 (d, J = 8.4 Hz, 
1H), 4.49 (app quin, J = 5.6 Hz, 1H), 4.30–4.23 (m, 1H), 3.68 
(app dt, J = 8.4, 4.8 Hz, 1H), 3.46 (d, J = 4.8 Hz, 1H), 3.41 (dd, 
J = 9.6, 4.8 Hz, 1H), 3.28 (dd, J = 9.6, 4.8 Hz, 1H), 1.56 (d, J = 
5.6 Hz, 3H: overlapped with water), 1.46 (s, 9H); 13C{1H} NMR 
(100 MHz, CDCl3) d 156.0, 143.2, 128.4, 128.0, 127.3, 87.3, 
84.0, 80.3, 72.5, 64.4, 51.9, 28.3, 14.3; HRMS (ESI) m/z calcd 
for C29H34N2NaO6 [M+Na]+ 529.2315, found 529.2306.   
6cb (5R isomer : 5S isomer = 5:1, only characteristic peaks 
of 5S isomer were described): Colorless solid; IR (film) 3424, 
3023, 2980, 2932, 1692, 1557, 1161, 760 cm–1; 1H NMR (400 
MHz, CDCl3) d 7.45–7.38 (m, 6H: overlapped with 5S isomer 
1.5H), 7.36–7.30 (m, 6H: overlapped with 5S isomer 1.5H), 
7.29–7.24 (m, 3H: overlapped with 5S isomer 0.75H and 
CHCl3), 5.06 (d, J = 9.6 Hz, 1H), 4.96 (d, J = 9.6 Hz, 0.25H: 5S 
isomer), 4.54 (dq, J = 9.6, 6.8 Hz, 1H), 4.38–4.30 (m, 0.25H: 
5S isomer), 4.12 (dd, J = 9.6, 3.6 Hz, 1H), 3.87 (app dt, J = 9.6, 
4.4 Hz, 1H), 3.68–3.58 (m, 0.25H: 5S isomer), 3.55 (dd, J = 9.6, 
4.4 Hz, 0.25H: 5S isomer), 3.40 (dd, J = 9.6, 4.4 Hz, 1H), 3.34 
(dd, J = 9.6, 4.4 Hz, 1H), 2.82 (d, J = 3.6 Hz, 1H), 2.55 (d, J = 
4.0 Hz, 0.25H: 5S isomer), 1.53 (d, J = 6.8 Hz, 3H), 1.46 (s, 9H), 
1.44 (s, 2.25H: 5S isomer); 13C{1H} NMR (100 MHz, CDCl3) d 
155.5, 143.2, 128.4, 128.1, 127.4, 87.5, 85.9, 80.2, 73.8, 64.9, 
49.8, 28.3, 16.1; HRMS (ESI) m/z calcd for C29H34N2NaO6 
[M+Na]+ 529.2315, found 529.2310.   
Synthesis of chiral nitroalkane 7c. 
tert-Butyl ((4R,5S)-2,2-Dimethyl-4-(1-nitroethyl)-1,3-
dioxan-5-yl)carbamate [(4S,5R)-7c] and 
(4S)-tert-Butyl-4-((1R)-1-hydroxy-2-nitropropyl)-2,2-
dimethyloxazolidine-3-carboxylate [(4S,5R)-8c] 
(4S,5R)-6ca (851 mg, 1.68 mmol) was dissolved in AcOH–
H2O = 9:1 (20.0 mL) and the resulting solution was stirred at 
ambient temperature for 24 h.  The reaction mixture was 
concentrated in vacuo, and the residue was purified by column 
chromatography on silica gel (hexane–EtOAc 1:1).  The 
obtained material was dissolved in 2,2-dimethoxypropane (8.00 
mL) and p-toluenesulfonic acid monohydrate (30.2 mg, 0.159 
mol) was added at ambient temperature.  After being stirred for 
3.5 h at same temperature, the reaction was quenched by the 
addition of saturated aqueous NaHCO3 solution and the mixture 
was extracted with EtOAc.  The organic layer was dried over 
Na2SO4, filtered and concentrated in vacuo.  The residue was 
purified by column chromatography on silica gel (hexane–
EtOAc 15:1) to afford (4S,5R)-7ca (309 mg, 1.01 mmol, 60% 
over 2 steps) and (4S,5R)-8ca (64.1 mg, 0.211 mmol, 13% over 
2 steps).   
(4S,5R)-7ca: Colorless solid; mp 104–105 °C; [a]27D –4.57 (c 
3.8, CHCl3); IR (film) 3455, 3316, 2982, 2911, 1715, 1553, 
1495, 1165, 849 cm–1; 1H NMR (400 MHz, CDCl3) d 5.26 (d, J 
= 10.0 Hz, 1H), 4.59 (app quin, J = 6.8 Hz, 1H), 4.36 (d, J = 7.6 
Hz, 1H), 4.09 (d, J = 10.8 Hz, 1H), 3.80–3.65 (m, 2H), 1.58 (d, 
J = 6.8 Hz, 3H), 1.49 (s, 3H), 1.45 (s, 9H), 1.41 (s, 3H); 13C{1H} 
NMR (100 MHz, CDCl3) d 155.2, 99.9, 81.8, 80.0, 72.0, 64.7, 
44.7, 29.3, 28.2, 18.4, 16.2; HRMS (ESI) m/z calcd for 
C13H24N2NaO6 [M+Na]+ 327.1532, found 327.1526.   
(4S,5R)-8ca: Colorless solid; mp 75–76 °C; [a]27D –43.5 (c 
1.0, CHCl3); IR (film) 3433, 2980, 2940, 1694, 1553, 1393, 
1165, 849 cm–1; 1H NMR (400 MHz, CDCl3) d 4.49 (br s, 1H), 
4.40 (br d, J = 6.0 Hz, 1H), 4.08 (app t, J = 7.2 Hz, 1H), 3.97 
(dd, J = 9.6, 6.0 Hz, 1H), 3.81 (br s, J = 8.4 Hz, 1H), 1.61 (br s, 
3H), 1.59 (d, J = 7.2 Hz, 3H), 1.51 (s, 3H), 1.49 (s, 9H); 13C{1H} 
NMR (100 MHz, CDCl3) d 155.6, 94.5, 84.2, 82.3, 75.1, 64.5, 
59.4, 28.3, 27.1, 24.0, 11.8; HRMS (ESI) m/z calcd for 
C13H24N2NaO6 [M+Na]+ 327.1532, found 327.1527.   
tert-Butyl ((4R,5S)-2,2-Dimethyl-4-(1-nitroethyl)-1,3-
dioxan-5-yl)carbamate [(4S,5R)-7cb] and 
(4S)-tert-Butyl-4-((1R)-1-hydroxy-2-nitropropyl)-2,2-
dimethyloxazolidine-3-carboxylate [(4S,5R)-8cb] 
Following the same procedure described for the conversion 
of (4S,5R)-6ca to (4S,5R)-7ca and (4S,5R)-8ca, (4S,5R)-6cb 
(1.68 g, 3.32 mmol) was converted to (4S,5R)-7cb (495 mg, 
1.63 mmol, 49% over 2 steps) and (4S,5R)-8cb (53.9 mg, 0.177 
mmol, 5% over 2 steps).   
(4S,5R)-7cb: Colorless solid; mp 94–96 °C; [a]27D –20.2 (c 
1.8, CHCl3); IR (film) 3377, 2982, 2944, 1713, 1557, 1501, 
1165, 847 cm–1; 1H NMR (400 MHz, CDCl3) d 5.36 (d, J = 10.4 
Hz, 1H), 4.56 (dq, J = 9.6, 6.8 Hz, 1H), 4.37 (dd, J = 9.6, 1.6 
Hz, 1H), 4.11 (dd, J = 12.0, 1.6 Hz, 1H), 3.76 (dd, J = 12.0, 2.0 
Hz, 1H), 3.70 (dd, J = 10.4, 2.0 Hz, 1H), 1.56 (d, J = 6.8 Hz, 
3H), 1.45 (s, 9H), 1.43 (s, 3H), 1.38 (s, 3H); 13C{1H} NMR (100 
MHz, CDCl3) d 155.3, 99.8, 84.8, 80.3, 73.2, 65.0, 44.0, 29.2, 
28.2, 18.0, 15.0; HRMS (ESI) m/z calcd for C13H24N2NaO6 
[M+Na]+ 327.1532, found 327.1529.   
(4S,5R)-8cb: Colorless solid; mp 82–84 °C; [a]27D –26.1 (c 
0.35, CHCl3); IR (film) 3337, 2980, 2942, 1715,1694, 1557, 
1393, 1165, 872 cm–1; 1H NMR (400 MHz, CDCl3) d 4.66–4.55 
(m, 1H), 4.53 (d, J = 10.0 Hz, 1H), 4.38 (dd, J = 10.0, 1.6 Hz, 
1H), 3.92 (dd, J = 11.2, 5.2 Hz, 1H), 3.75–3.65 (m, 1H), 3.59 
(dd, J = 11.2, 8.8 Hz, 1H), 1.62 (d, J = 6.8 Hz, 3H), 1.42 (s, 9H), 
1.40 (s, 3H), 1.36 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) d 
155.1, 99.3, 82.4, 80.5, 74.0, 62.9, 45.8, 28.2, 27.7, 19.3, 11.1; 
HRMS (ESI) m/z calcd for C13H24N2NaO6 [M+Na]+ 327.1532, 
found 327.1523.   
The 2nd Henry reaction.   
tert-Butyl ((4R,5S)-4-((R)-1-Hydroxy-2-nitropropan-2-yl)-
2,2-dimethyl-1,3-dioxan-5-yl)carbamate [(4S,5R,6R)-4c] and 
tert-Butyl ((4R,5S)-4-((S)-1-Hydroxy-2-nitropropan-2-yl)-
2,2-dimethyl-1,3-dioxan-5-yl)carbamate [(4S,5R,6S)-4c] 
A two-neck flask charged with MgCl2·6H2O (11.2 mg, 55.1 
µmol) was heated by a heat-gun under vacuum for five minutes 
(Note: the appearance of MgCl2·6H2O, which was initially a 
 
colorless solid, was changed to white solid during this step).  
After cooling down to ambient temperature, the flask was 
purged with nitrogen.  To the flask was added NaOt-Bu (10.6 
mg, 0.110 mmol) and THF (0.500 mL), and resulting mixture 
was stirred at ambient temperature for 30 minutes before it was 
cooled to 0 °C.  To this solution was then added a solution of 
(4S,5R)-7ca (54.7 mg, 0.180 mmol) in THF (1.00 mL) followed 
by (HCHO)n (17.2 mg, 0.572 mmol).  After being stirred at 
same temperature for 1.5 h, the reaction was quenched by the 
addition of saturated aqueous NH4Cl solution at 0°C.  The 
mixture was extracted with EtOAc and combined organic layer 
was dried over Na2SO4.  After filtration, the solvent was 
removed in vacuo and the crude material was subjected to 
column chromatography on silica gel (hexane–EtOAc 4:1) to 
afford 4c (55.5 mg, 0.166 mmol, 92%, 6R/6S = 6:1). Further 
purification was carried out by column chromatography on 
silica gel (CH2Cl2–EtOAc 7:1) to separate (4S,5R,6R)-4c (45.7 
mg, 0.137 mmol, 76%) and (4S,5R,6S)-4c (7.2 mg, 21.6 µmol, 
12%).   
(4S,5R)-7cb (322 mg, 1.06 mmol) was also converted to 4c 
(284 mg, 0.849 mmol, 80%, 6R/6S = 5:1) according to the same 
manner as (4S,5R)-7ca.   
(4S,5R,6R)-4c: Colorless solid; mp 75–77 °C; [a]24D –16.2 (c 
0.50, CHCl3); IR (film) 3445, 2982, 2942, 1694, 1549, 1505, 
1368, 1163, 1099, 764 cm–1; 1H NMR (400 MHz, CDCl3) d 5.35 
(d, J = 10.0 Hz, 1H), 4.92 (app s, 1H), 4.16 (d, J = 12.0 Hz, 1H), 
4.05 (dd, J = 12.0, 7.2 Hz, 1H), 3.93 (dd, J = 12.0, 4.0 Hz, 1H), 
3.84 (d, J = 10.0 Hz, 1H), 3.68 (dd, J = 12.0, 2.0 Hz, 1H), 2.83 
(br s, 1H), 1.54 (s, 3H), 1.46 (s, 3H), 1.44 (s, 9H), 1.40 (s, 3H); 
13C{1H} NMR (100 MHz, CDCl3) d 155.4, 100.3, 94.8, 80.4, 
72.0, 66.6, 65.9, 45.0, 29.3, 28.3, 18.0, 14.9; HRMS (ESI) m/z 
calcd for C14H26N2NaO7 [M+Na]+ 357.1638, found 357.1630.   
(4S,5R,6S)-4c: Colorless solid; mp 94–96 °C; [a]24D –4.85 (c 
1.57, CHCl3); IR (film) 3451, 2982, 2940, 1699, 1547, 1505, 
1163, 1096, 853 cm–1; 1H NMR (400 MHz, CDCl3) d 5.37 (d, J 
= 10.0 Hz, 1H), 4.77 (app s, 1H), 4.23 (d, J = 12.8 Hz, 1H), 4.10 
(d, J = 12.0 Hz, 1H), 3.92 (d, J = 12.8 Hz, 1H), 3.84 (d, J = 10.0 
Hz, 1H), 3.71 (d, J = 12.0 Hz, 1H), 2.74 (br s, 1H), 1.58 (s, 3H), 
1.44 (s, 9H), 1.44 (s, 3H), 1.39 (s, 3H); 13C{1H} NMR (100 
MHz, CDCl3) d 155.1, 100.5, 93.6, 80.5, 74.9, 66.4, 64.1, 44.9, 
29.2, 28.3, 18.2, 17.7; HRMS (ESI) m/z calcd for 
C14H26N2NaO7 [M+Na]+ 357.1638, found 357.1636.   
 




(4S,5R,6R)-4c (64.4 mg, 0.193 mmol) was dissolved in i-
PrOH–AcOH = 2:1 (1.50 mL) at ambient temperature, and 
resulting solution was treated with Zn dust (125 mg, 1.93 mmol) 
which was added in 3 portions every hour.  The mixture was 
further stirred at ambient temperature for 3 h.  After the period 
of time, the mixture was filtered through a pad of Celite® and 
concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (EtOAc–MeOH 20:1).  The 
obtained material was dissoleved in CH2Cl2 (2.00 mL) and 
treated with Et3N (80 µL, 0.579 mmol) and (Boc)2O (62.5 mg, 
0.290 mmol) at 40 °C for 6 h.  The reaction was quenched by 
the addition of water at 40 °C. The resultant mixture was 
extracted with CH2Cl2, dried over Na2SO4, filtered and 
concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (hexane–AcOEt 3:1) to afford 9 
(46.7 mg, 0.116 mmol, 60% over 2 steps).   
9: Colorless solid; mp 129–130 °C; [a]23D –10.6 (c 0.57, 
CHCl3); IR (film) 3447, 2978, 2934, 1715, 1699, 1506, 1368, 
1171, 1076, 856 cm–1; 1H NMR (400 MHz, CDCl3) d 5.27 (br 
s, 1H), 4.93 (s, 1H), 4.31 (app s, 1H), 4.06 (d, J = 12.0 Hz, 1H), 
3.90 (br d, J = 9.6 Hz, 1H), 3.86–3.80 (m, 1H), 3.73 (dd, J = 
12.0, 4.4 Hz, 1H), 3.68 (dd, J = 12.0, 2.0 Hz, 1H), 1.48–1.43 (m, 
15H), 1.43 (s, 9H), 1.19 (s, 3H); 13C{1H} NMR (100 MHz, 
CDCl3) d 156.0, 155.0, 100.0, 79.9, 72.2, 67.3, 66.7, 59.1, 45.2, 
29.6, 28.4, 28.3, 27.7, 18.7, 18.5; HRMS (ESI) m/z calcd for 
C19H36N2NaO7 [M+Na]+ 427.2420, found 427.2428.   
Di-tert-butyl ((2R,3R,4S)-1,3,5-Trihydroxy-2-
methylpentane-2,4-diyl)dicarbamate [10] 
Acetonide 9 (23.7 mg, 58.6 µmol) was dissolved in AcOH–
H2O = 9:1 (1.00 mL) at ambient temperature, and the solution 
was stirred at same temperature for 4 h.  The solvent was 
removed in vacuo at 40 °C.  The residue was purified by column 
chromatography on silica gel (hexane–EtOAc 1:1) to afford 10 
(16.2 mg, 44.5 µmol, 76%).   
10: colorless solid; mp 140–142 °C; [a]20D –22.5 (c 0.47, 
CHCl3); IR (KBr) 3450, 3291, 2979, 1670, 1506, 1365, 1178, 
1022 cm–1; 1H NMR (400 MHz, CDCl3) d 5.48 (br s, 1H), 5.35 
(d, J = 9.2 Hz, 1H), 5.16 (br s, 1H), 4.02 (d, J = 4.0 Hz, 1H), 
3.97 (d, J = 11.6 Hz, 1H), 3.94–3.87 (m, 1H), 3.85–3.72 (m, 
2H), 3.71–3.60 (m, 2H), 3.15 (br s, 1H), 1.45 (s, 9H), 1.43 (s, 
9H), 1.23 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) d 157.2, 
156.1, 80.5, 79.8, 75.7, 67.6, 65.9, 59.2, 50.7, 28.4, 28.3, 20.1; 
HRMS (FAB) m/z calcd for C16H33N2O7 [M+H]+ 365.2288, 




To a solution of 10 (14.7 mg, 40.3 µmol) in CH2Cl2 (2.00 mL) 
was added PhI(OAc)2 (39.5 mg, 0.123 mmol) and TEMPO (1.3 
mg, 8.30 µmol) at ambient temperature.  After being stirred at 
same temperature for 4 h, the reaction was quenched by the 
addition of saturated aqueous Na2S2O3 solution.  The resulting 
mixture was extracted with Et2O, dried over Na2SO4, filtered 
and concentrated in vacuo to give the crude product.  The 
residue was purified by column chromatography on silica gel 
(hexane–EtOAc 5:1) to afford Mohapatra’s intermediate (3) 
(11.7 mg, 32.5 µmol, 81%).   
3: colorless solid; mp 151–153 °C; [a]20D –20.4 (c 0.33, 
CHCl3); IR (KBr) 3419, 3019, 2981, 2933, 1754 cm–1; 1H NMR 
(600 MHz, CDCl3) d 5.69 (br s, 1H), 4.91 (br s, 1H), 4.73 (br s, 
1H), 4.39 (d, J = 12.0 Hz, 1H), 4.34 (d, J = 12.0 Hz, 1H), 4.15–
4.09 (m, 1H), 3.95 (d, J = 5.4 Hz, 1H), 1.45 (s, 9H), 1.41 (s, 9H), 
1.38 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) d 169.4, 157.3, 
154.6, 81.5, 80.4, 76.4, 70.9, 57.3, 55.4, 28.3, 28.2, 16.6; 
HRMS (FAB) m/z calcd for C16H29N2O7 [M+H]+ 361.1975, 
found 361.1969.   
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